KORU Medical Systems Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Details Narrative)

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)										3 Months Ended
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	Mar. 22, 2021	Mar. 15, 2021	Feb. 16, 2021	Jan. 15, 2021	Jan. 02, 2021	Oct. 01, 2019	May 20, 2019	Apr. 23, 2019	Jan. 02, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Non-Employee Director [Member]
Nonemployee services transaction cost									$ 50,000
Amount for chairing board committee									$ 10,000
Board of Directors Chairman [Member]
Nonemployee services transaction cost					$ 100,000	$ 50,000
Description of non employee services transaction					To be paid quarterly $12,500 in cash and $12,500 in common stock.
Non-Employee Director and Board Advisor [Member]
Nonemployee services transaction cost					$ 75,000
Description of non employee services transaction					To be paid quarterly $12,500 in cash and $6,250 in common stock.
Settlement Agreement [Member] \| EMED Technologies Corporation [Member]
Description of vesting rights							the Company issued to EMED (i) 95,238 restricted stock units, which vested on May 21, 2020 and 95,238 restricted stock units, which vested on January 1, 2021, and (ii) an option to purchase up to 400,000 shares of the Company’s common stock at an exercise price of $11.21 per share prior to February 1, 2021, which was not exercised.
Employees and Consultants under the Plan [Member]
Number of stock option shares										1,250,000
Number of stock option shares issued										3,172,494
2015 Stock Option Plan [Member]
Number of stock option shares								6,000,000
2015 Stock Option Plan [Member] \| Time Based Shares Options [Member]
Weighted average grant date fair value of stock options										$ 3.06	$ 0.00
Allocated stock-based compensation expense										$ 1,086,681	$ 175,239
Weighted-average grant-date fair value options granted										3,800,000	0
Total unrecognized compensation cost										$ 6,100,000
Weighted-average period (in years)										46 months
Total fair value of shares vested										$ 1,230,434	$ 868,012
Number of options outstanding										3,172,494	3,472,000	2,922,494	3,647,000
Cash received from option exercises										$ 1,230,000	$ 85,500
Number of options exercised										1,000,000	175,000
Tax benefits associated with stock-based compensation										$ 43,067	$ 15,598
Stock-based compensation expense										$ 1,086,681	$ 175,239
2015 Stock Option Plan [Member] \| Performance Based Share Options [Member]
Weighted average grant date fair value of stock options
Allocated stock-based compensation expense										$ (408,747)	$ 125,727
Total unrecognized compensation cost										0
Total fair value of shares vested										$ 0	$ 0
Number of options outstanding											1,000,000	1,000,000	1,000,000
Stock-based compensation expense										$ (408,747)	$ 125,727
Donald Pettigrew [Member]
Cash received from option exercises			$ 1,230,000
Number of options exercised			1,000,000
Linda Tharby [Member]
Number of stock option shares issued		1,000,000
exercise price		$ 3.875
Description of vesting rights		25% on March 15, 2022 and 25% each twelve months thereafter.
James M. Beck [Member]
Number of stock option shares issued				150,000
exercise price				$ 4.37
Number of shares vested	50,000			100,000